Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Cash from Operations (2021 - 2025)

Historic Cash from Operations for P3 Health Partners (PIIIW) over the last 5 years, with Q3 2025 value amounting to -$15.4 million.

  • P3 Health Partners' Cash from Operations rose 3185.96% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.7 million, marking a year-over-year decrease of 7849.73%. This contributed to the annual value of -$110.1 million for FY2024, which is 4485.19% down from last year.
  • Latest data reveals that P3 Health Partners reported Cash from Operations of -$15.4 million as of Q3 2025, which was up 3185.96% from -$16.6 million recorded in Q2 2025.
  • P3 Health Partners' 5-year Cash from Operations high stood at -$5.7 million for Q3 2021, and its period low was -$57.2 million during Q4 2024.
  • For the 5-year period, P3 Health Partners' Cash from Operations averaged around -$22.6 million, with its median value being -$21.0 million (2022).
  • In the last 5 years, P3 Health Partners' Cash from Operations crashed by 26830.41% in 2022 and then surged by 6448.93% in 2024.
  • P3 Health Partners' Cash from Operations (Quarter) stood at -$11.3 million in 2021, then crashed by 182.74% to -$32.0 million in 2022, then surged by 50.31% to -$15.9 million in 2023, then tumbled by 260.49% to -$57.2 million in 2024, then skyrocketed by 73.07% to -$15.4 million in 2025.
  • Its last three reported values are -$15.4 million in Q3 2025, -$16.6 million for Q2 2025, and -$33.5 million during Q1 2025.